Predictions
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.62
03.12.21
03.12.21
-
03.12.22
03.12.22
0.84%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Radius Health Inc.
Start price
Target price
Perf. (%)
€13.05
05.12.21
05.12.21
-
05.12.22
05.12.22
-48.66%
11.12.21
11.12.21
Risky Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.28
02.12.21
02.12.21
-
02.12.22
02.12.22
-0.61%
11.12.21
11.12.21
Risky Investment
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.42
03.12.21
03.12.21
-
03.12.22
03.12.22
7.50%
11.12.21
11.12.21
Risky Investment
Aldeyra Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.90
07.12.21
07.12.21
-
07.12.22
07.12.22
4.24%
11.12.21
11.12.21
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.96
01.12.21
01.12.21
€6.00
01.12.22
01.12.22
-2.70%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
Ardelyx Inc.
Start price
Target price
Perf. (%)
€0.99
30.11.21
30.11.21
€1.00
30.11.22
30.11.22
36.36%
11.12.21
11.12.21
Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
Krystal Biotech
Start price
Target price
Perf. (%)
€77.00
29.11.21
29.11.21
-
29.11.22
29.11.22
-19.48%
10.12.21
10.12.21
Probably not worthwhile Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€3.44
08.09.21
08.09.21
-
08.09.22
08.09.22
-34.88%
08.12.21
08.12.21
Could be worthwhile Investment >10% per year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.00
05.10.21
05.10.21
-
05.10.22
05.10.22
-10.00%
08.12.21
08.12.21
Probably not worthwhile Investment
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.51
07.12.20
07.12.20
€25.00
07.12.21
07.12.21
93.92%
08.12.21
08.12.21
Could be very worthwhile Investment >20% year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€76.10
09.07.21
09.07.21
-
09.07.22
09.07.22
-25.49%
05.12.21
05.12.21
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€3.58
04.12.20
04.12.20
-
04.12.21
04.12.21
282.12%
05.12.21
05.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€151.00
02.12.20
02.12.20
-
02.12.21
02.12.21
-42.05%
03.12.21
03.12.21
Risky Investment
Krystal Biotech
Start price
Target price
Perf. (%)
€42.60
30.10.21
30.10.21
€37.00
30.11.22
30.11.22
54.93%
01.12.21
01.12.21
Could be very worthwhile Investment >20% year
Abivax S.A.
Start price
Target price
Perf. (%)
€30.50
28.06.21
28.06.21
€25.00
28.06.22
28.06.22
-16.39%
01.12.21
01.12.21
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE
Start price
Target price
Perf. (%)
€11.84
13.09.21
13.09.21
-
13.09.22
13.09.22
139.19%
29.11.21
29.11.21
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Axonics Modulation Technologies Inc
Start price
Target price
Perf. (%)
€37.20
28.11.20
28.11.20
€42.00
28.11.21
28.11.21
31.72%
29.11.21
29.11.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.50
22.11.21
22.11.21
-
22.11.22
22.11.22
-2.83%
28.11.21
28.11.21
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€6.92
10.07.21
10.07.21
€5.80
10.07.22
10.07.22
-6.86%
27.11.21
27.11.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€37.75
17.11.21
17.11.21
€50.00
17.11.22
17.11.22
4.64%
27.11.21
27.11.21
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
Valneva SE
Start price
Target price
Perf. (%)
€21.24
15.11.21
15.11.21
€25.00
15.11.22
15.11.22
33.24%
27.11.21
27.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Catalyst Biosciences Inc
Start price
Target price
Perf. (%)
€0.79
13.11.21
13.11.21
€0.000
13.11.22
13.11.22
-26.11%
27.11.21
27.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.97
15.11.21
15.11.21
-
15.11.22
15.11.22
-28.16%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Boiron S.A.
Start price
Target price
Perf. (%)
€38.55
13.04.21
13.04.21
€36.00
13.04.22
13.04.22
-1.30%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year